BR9916265A - Formulações de doramectina - Google Patents

Formulações de doramectina

Info

Publication number
BR9916265A
BR9916265A BR9916265-2A BR9916265A BR9916265A BR 9916265 A BR9916265 A BR 9916265A BR 9916265 A BR9916265 A BR 9916265A BR 9916265 A BR9916265 A BR 9916265A
Authority
BR
Brazil
Prior art keywords
doramectin
formulations
injection
invention patent
wide spectrum
Prior art date
Application number
BR9916265-2A
Other languages
English (en)
Inventor
Valerie Denise Harding
Stephen Richard Wicks
Timothy Michael Lukas
Snezana Milojevic
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9916265A publication Critical patent/BR9916265A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Patente de Invenção: "FORMULAçõES DE DORAMECTINA".Formulações antiparasitárias de largo espectro de doramectina,adequadas para injeção, como aqui descritas.
BR9916265-2A 1998-12-16 1999-11-22 Formulações de doramectina BR9916265A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9827727.0A GB9827727D0 (en) 1998-12-16 1998-12-16 Antiparasitic formulations
PCT/IB1999/001854 WO2000035445A1 (en) 1998-12-16 1999-11-22 Doramectin formulations

Publications (1)

Publication Number Publication Date
BR9916265A true BR9916265A (pt) 2001-11-20

Family

ID=10844352

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916265-2A BR9916265A (pt) 1998-12-16 1999-11-22 Formulações de doramectina

Country Status (21)

Country Link
US (1) US6699847B2 (pt)
EP (1) EP1140068B1 (pt)
JP (1) JP3848537B2 (pt)
AP (1) AP9901699A0 (pt)
AR (1) AR019499A1 (pt)
AT (1) ATE269074T1 (pt)
AU (1) AU762892B2 (pt)
BR (1) BR9916265A (pt)
CA (1) CA2355102C (pt)
DE (1) DE69918165T2 (pt)
DK (1) DK1140068T3 (pt)
ES (1) ES2221455T3 (pt)
GB (1) GB9827727D0 (pt)
GT (1) GT199900213A (pt)
MA (1) MA26710A1 (pt)
PA (1) PA8486601A1 (pt)
PE (1) PE20001244A1 (pt)
PT (1) PT1140068E (pt)
TN (1) TNSN99225A1 (pt)
TW (1) TW524691B (pt)
WO (1) WO2000035445A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9877612B2 (en) 2012-11-09 2018-01-30 Aktiebolaget Electrolux Blender jar, blender base unit and blender

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013142A1 (fr) * 2002-08-02 2004-02-12 The Institute Of Radiation Medicine, Academy Of Miilitary Medical Sciences, People's Liberation Army Derive de riboflavine ainsi que sa fabrication et ses utilisations
AU2003235019A1 (en) * 2003-08-17 2005-03-03 Sirene Call Pty Ltd Attract-and-Kill Method of Controlling Ecto-Parasites from the Order Acarina in Livestock and Domestic Animals as well as Members of the Order Artiodactyle
WO2010008891A2 (en) * 2008-06-24 2010-01-21 Merial Limited Anthelminthic formulations
MX2009001235A (es) * 2008-09-19 2010-04-29 Agrovet Market S A Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
JP2012517994A (ja) 2009-02-16 2012-08-09 ファイザー・インク 高投与量ドラメクチン製剤
CN103417477B (zh) * 2012-05-18 2015-08-05 中国农业科学院兰州畜牧与兽药研究所 一种以水为基质的多拉菌素o/w型注射液及其制备方法
EA037747B1 (ru) * 2019-04-01 2021-05-18 Севиндж Аллахверди кызы АЛИЕВА Антипаразитарное средство

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL151903B (nl) 1965-03-24 1977-01-17 Schering Ag Werkwijze ter bereiding van een injectievloeistof door een steroid op te lossen in een mengsel van ricinusolie en benzylbenzoaat.
DE3377064D1 (en) 1982-12-28 1988-07-21 Bayer Ag Stable aminoglycoside-penicillin injection formulation
DE3484584D1 (de) 1983-10-14 1991-06-20 Sumitomo Pharma Injektionen mit verzoegerter abgabe.
IL79765A (en) 1985-08-23 1992-02-16 Lilly Co Eli Injectable sustained release formulations of bovine somatotropin
ES2052173T3 (es) 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
NZ234802A (en) 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
ES2131515T3 (es) 1991-09-30 1999-08-01 Merck & Co Inc Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
DE4410970C1 (de) 1994-03-29 1995-07-20 Talbot Waggonfab Wankstütze für Schienenfahrzeuge mit einer Querneigeeinrichtung
US5580574A (en) 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
CA2233016C (en) * 1995-09-25 2007-07-17 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9877612B2 (en) 2012-11-09 2018-01-30 Aktiebolaget Electrolux Blender jar, blender base unit and blender

Also Published As

Publication number Publication date
PE20001244A1 (es) 2000-11-07
AU1069900A (en) 2000-07-03
TNSN99225A1 (fr) 2005-11-10
CA2355102A1 (en) 2000-06-22
DE69918165T2 (de) 2004-10-14
AP9901699A0 (en) 2001-05-22
DE69918165D1 (de) 2004-07-22
JP2002532422A (ja) 2002-10-02
PA8486601A1 (es) 2000-09-29
CA2355102C (en) 2006-07-11
EP1140068A1 (en) 2001-10-10
AU762892B2 (en) 2003-07-10
PT1140068E (pt) 2004-09-30
EP1140068B1 (en) 2004-06-16
GB9827727D0 (en) 1999-02-10
GT199900213A (es) 2001-06-07
ATE269074T1 (de) 2004-07-15
US6699847B2 (en) 2004-03-02
DK1140068T3 (da) 2004-07-12
ES2221455T3 (es) 2004-12-16
AR019499A1 (es) 2002-02-20
US20020142972A1 (en) 2002-10-03
TW524691B (en) 2003-03-21
JP3848537B2 (ja) 2006-11-22
MA26710A1 (fr) 2004-12-20
WO2000035445A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
BR9916896A (pt) Diaril aminas substituìdas com 1-heterociclo
BR9902086A (pt) Formulações farmacêuticas.
EP1760067A3 (en) Compounds with protected hydroxy groups
HRP20030383B1 (en) Lactam compound
IL129592A0 (en) 5-HT1f agonists
EP1208085A4 (en) BENZANILIDE AS THE OPENER OF THE POTASSIUM CHANNEL
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
ATE288900T1 (de) Substituierte benzoylcyclohexandione
BR9916265A (pt) Formulações de doramectina
DE29821541U1 (de) Azidfreie, gaserzeugende Zusammensetzung
BR9902084A (pt) Heterociclos.
PT882726E (pt) Carbazol-carboxamidas como agonistas 5-ht1f
BR9811826A (pt) Processo melhorado para agente antiparasìtico
BR9916615A (pt) Método para a preparação de éteres de arila
TR199901209T2 (xx) B�cek �ld�r�c� ve mitisidal kompozisyonlar
DK1204659T3 (da) Serotonerge benzofuraner
BR0208654A (pt) Composições veterinárias compreendendo derivados de avermectina-oxima e praziquantel
IL135634A0 (en) 5-htif agonists
BR9810433A (pt) Composições anti-helmìnticas
MY130532A (en) Combination of biological and chemical agents to combat rodents
ZA978406B (en) Nodulisporic acid derivatives.
PT1234817E (pt) Processo para a preparacao de midodrina

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA ( ART. 8O COMBINADO COM 13 DA LPI ) AS REIVINDICACOES NAO ESTAO DEFINIDAS DE MODO CLARO E PRECISO ( ART. 25 DA LPI )

B12B Appeal against refusal [chapter 12.2 patent gazette]